The presence of this variant was associated with increased immune cell infiltration of tumour tissues and a lower frequency of beta-catenin mutations (CTNNB1) which frequently precede HCC occurrence.39 This protective effect of rs708113 was not observed in people with HCC on a background of chronic HCV infection or NAFLD.14 Here, CTNNB1 is linked to metabolic dysfunction-associated steatotic liver disease.